|
|
Article: Interferon Sciences Announces Delay in Releasing Year-End 2002 Financial Statements and Decision to Restate 2001 and 2000 Financial Results.
- Article from:
- Business Wire
- Article date:
- June 10, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--June 10, 2003
Interferon Sciences, Inc. (ISI) (OTC-BB:IFSC) announced today that its recently engaged independent certified public accountants, Eisner LLP, are in the process of auditing the Company's financial statements for the year ended December 31, 2002, and re-auditing the years ended December 31, 2001 and 2000.
The Company intends to restate the financial statements for the years ended December 31, 2001 and 2000 and therefore, neither the financial statements nor the report of KPMG LLP on such financial statements should be relied upon. Although the adjustments to the previously ...